153 related articles for article (PubMed ID: 19793901)
1. Cellular targeting of engineered heterologous antigens is a determinant factor for bovine herpesvirus 4-based vaccine vector development.
Donofrio G; Franceschi V; Capocefalo A; Taddei S; Sartori C; Bonomini S; Cavirani S; Cabassi CS; Flammini CF
Clin Vaccine Immunol; 2009 Nov; 16(11):1675-86. PubMed ID: 19793901
[TBL] [Abstract][Full Text] [Related]
2. A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle.
Williams LBA; Fry LM; Herndon DR; Franceschi V; Schneider DA; Donofrio G; Knowles DP
PLoS One; 2019; 14(4):e0215605. PubMed ID: 31002724
[TBL] [Abstract][Full Text] [Related]
3. Swine adipose stromal cells loaded with recombinant bovine herpesvirus 4 virions expressing a foreign antigen induce potent humoral immune responses in pigs.
Donofrio G; Taddei S; Franceschi V; Capocefalo A; Cavirani S; Martinelli N; Ottonello S; Ferrari M
Vaccine; 2011 Jan; 29(5):867-72. PubMed ID: 21115049
[TBL] [Abstract][Full Text] [Related]
4. Recombinant bovine herpesvirus 4 (BoHV-4) expressing glycoprotein D of BoHV-1 is immunogenic and elicits serum-neutralizing antibodies against BoHV-1 in a rabbit model.
Donofrio G; Cavirani S; Vanderplasschen A; Gillet L; Flammini CF
Clin Vaccine Immunol; 2006 Nov; 13(11):1246-54. PubMed ID: 16928886
[TBL] [Abstract][Full Text] [Related]
5. Double immunization strategy with a BoHV-4-vectorialized secreted chimeric peptide BVDV-E2/BoHV-1-gD.
Donofrio G; Sartori C; Franceschi V; Capocefalo A; Cavirani S; Taddei S; Flammini CF
Vaccine; 2008 Nov; 26(48):6031-42. PubMed ID: 18812200
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Bovine Herpesvirus Type I Expressing the Bovine Viral Diarrhea Virus E2 Protein Could Effectively Prevent Infection by Two Viruses.
Liu CY; Guo H; Zhao HZ; Hou LN; Wen YJ; Wang FX
Viruses; 2022 Jul; 14(8):. PubMed ID: 35893683
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a bovine herpesvirus 4 based vector expressing a secreted form of the bovine viral diarrhoea virus structural glycoprotein E2 for immunization purposes.
Donofrio G; Sartori C; Ravanetti L; Cavirani S; Gillet L; Vanderplasschen A; Taddei S; Flammini CF
BMC Biotechnol; 2007 Oct; 7():68. PubMed ID: 17945009
[TBL] [Abstract][Full Text] [Related]
8. Efficient heterologous antigen gene delivery and expression by a replication-attenuated BoHV-4-based vaccine vector.
Capocefalo A; Mangia C; Franceschi V; Jacca S; van Santen VL; Donofrio G
Vaccine; 2013 Aug; 31(37):3906-14. PubMed ID: 23830977
[TBL] [Abstract][Full Text] [Related]
9. Construction of chimeric bovine viral diarrhea viruses containing glycoprotein E rns of heterologous pestiviruses and evaluation of the chimeras as potential marker vaccines against BVDV.
Luo Y; Yuan Y; Ankenbauer RG; Nelson LD; Witte SB; Jackson JA; Welch SK
Vaccine; 2012 Jun; 30(26):3843-8. PubMed ID: 22521286
[TBL] [Abstract][Full Text] [Related]
10. Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen.
Franceschi V; Capocefalo A; Calvo-Pinilla E; Redaelli M; Mucignat-Caretta C; Mertens P; Ortego J; Donofrio G
Vaccine; 2011 Apr; 29(16):3074-82. PubMed ID: 21320537
[TBL] [Abstract][Full Text] [Related]
11. Effect of vaccination of pregnant beef heifers on the concentrations of serum IgG and specific antibodies to bovine herpesvirus 1, bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2 in heifers and calves.
Reppert EJ; Chamorro MF; Robinson L; Cernicchiaro N; Wick J; Weaber RL; Haines DM
Can J Vet Res; 2019 Oct; 83(4):313-316. PubMed ID: 31571732
[TBL] [Abstract][Full Text] [Related]
12. Protective immunity following vaccination with a recombinant multiple-epitope protein of bovine herpesvirus type I in a rabbit model.
Wen X; Tong X; Wang M; Wang J; Ni H; Ran X
Appl Microbiol Biotechnol; 2020 Apr; 104(7):3011-3023. PubMed ID: 32002602
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins.
Rosas CT; König P; Beer M; Dubovi EJ; Tischer BK; Osterrieder N
J Gen Virol; 2007 Mar; 88(Pt 3):748-757. PubMed ID: 17325347
[TBL] [Abstract][Full Text] [Related]
14. Development of a BoHV-4 viral vector expressing tgD of BoHV-1 and evaluation of its immunogenicity in mouse model.
Bilge-Dagalp S; Farzani TA; Dogan F; Akkutay Yoldar Z; Ozkul A; Alkan F; Donofrio G
Braz J Microbiol; 2021 Sep; 52(3):1119-1133. PubMed ID: 34255309
[TBL] [Abstract][Full Text] [Related]
15. Construction and immunogenicity of the recombinant Lactobacillus acidophilus pMG36e-E0-LA-5 of bovine viral diarrhea virus.
Zhao Y; Jiang L; Liu T; Wang M; Cao W; Bao Y; Qin J
J Virol Methods; 2015 Dec; 225():70-5. PubMed ID: 26386184
[TBL] [Abstract][Full Text] [Related]
16. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
[TBL] [Abstract][Full Text] [Related]
17. Immune responses in bovines to recombinant glycoprotein D of bovine herpesvirus type 5 as vaccine antigen.
Araujo IL; Dummer LA; Rodrigues PRC; Dos Santos AG; Fischer G; Cunha RC; Leite FPL
Vaccine; 2018 Nov; 36(50):7708-7714. PubMed ID: 30381153
[TBL] [Abstract][Full Text] [Related]
18. Experimental immunization of mice with a recombinant bovine enterovirus vaccine expressing BVDV E0 protein elicits a long-lasting serologic response.
Ren X; Zhang S; Gao X; Guo X; Xin T; Zhu H; Jia H; Hou S
Virol J; 2020 Jul; 17(1):88. PubMed ID: 32611446
[TBL] [Abstract][Full Text] [Related]
19. Clinical protection of goats against CpHV-1 induced genital disease with a BoHV-4-based vector expressing CpHV-1 gD.
Donofrio G; Franceschi V; Lovero A; Capocefalo A; Camero M; Losurdo M; Cavirani S; Marinaro M; Grandolfo E; Buonavoglia C; Tempesta M
PLoS One; 2013; 8(1):e52758. PubMed ID: 23300989
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of bovine herpesvirus type 1 by deletion of its glycoprotein G and tk genes and protection against virulent viral challenge.
Zhang M; Fu S; Deng M; Xie Q; Xu H; Liu Z; Hu C; Chen H; Guo A
Vaccine; 2011 Nov; 29(48):8943-50. PubMed ID: 21959327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
